Vertex’s Journavx Approved by FDA, Offers Hope for Opioid Alternatives
31 Jan 2025
The FDA approved a new pain medication designed to reduce the risks of addiction and overdose linked to opioids like Vicodin and OxyContin on Thursday. The drug, called Journavx, was developed by Vertex Pharmaceuticals and targets short-term pain following surgery or injury. A New Approach to Pain Relief Journavx offers...
Read More